Comparing clinical and radiological effectiveness of disease modifying treatments in the real-world

被引：0

作者：

Moccia, M. ^{[1
]}

Al-Araji, S. ^{[1
]}

Zhang, L. ^{[1
]}

Abdel-Mannan, O. ^{[1
]}

Aojula, A. ^{[1
]}

Bianchi, A. ^{[1
]}

Champsas, D. ^{[1
]}

Eshaghi, A. ^{[1
]}

Goodkin, O. ^{[1
]}

Hamed, W. ^{[1
]}

Pontillo, G. ^{[1
]}

Yam, C. ^{[1
]}

Wilkins, D. ^{[1
]}

Brownlee, W. ^{[2
]}

Chard, D. ^{[2
]}

Chataway, J. ^{[2
]}

Chung, K. ^{[2
]}

De Angelis, F. ^{[2
]}

Khaleeli, Z. ^{[2
]}

Leary, S. ^{[2
]}

Swanton, J. ^{[2
]}

Thompson, A. ^{[2
]}

Toosy, A. T. ^{[2
]}

Trip, Sa. ^{[2
]}

Wilson, H. ^{[2
]}

Barkhof, F. ^{[3
]}

Ciccarelli, O. ^{[4
]}

机构：

[1] UCL, Queen Sq MS Ctr, Dept Neuroinflammat, UCL Queen Sq,Inst Neurol,Fac Brain Sci, London, England

[2] Natl Hosp Neurol & Neurosurg, London, England

[3] UCL, Translat Imaging Grp, UCL Inst Healthcare Engn, London, England

[4] UCL, Hosp Biomed Res Ctr, Nat Inst Hlth Res, London, England

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O018

引用

页码：10 / 11

页数：2

共 50 条

[21] REAL-WORLD EFFECTIVENESS OF BISPHOSPHONATES FOR THE REDUCTION OF CLINICAL FRACTURES
Thomas, T.
Ringe, J. D.
Gold, D. T.
Lange, J. L.
Abelson, A.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 184 - 185
[22] REAL-WORLD EFFECTIVENESS OF BISPHOSPHONATES FOR THE REDUCTION OF CLINICAL FRACTURES
Ringe, J.
Thomas, T.
Gold, D.
Lange, J.
Abelson, A.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 20 - 21
[23] Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
Fernandez-Guarino, Montserrat
Ortiz, Pablo
Gallardo, Fernando
Llamas-Velasco, Mar
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
[24] Response to "Liraglutide Effectiveness: Is There a Real-World Clinical Benefit?"
Wharton, Sean
Liu, Aiden
Pakseresht, Arash
Nortoft, Emil
Haase, Christiane L.
Mancini, Johanna
Power, G. Sarah
Vanderlelie, Sarah
Christensen, Rebecca A. G.
OBESITY, 2019, 27 (11) : 1728 - 1728
[25] Liraglutide Effectiveness in Real-World Clinical Setting in Croatia
Berkovic, Maja Cigrovski
Bilic-Curcic, Ines
Gradiser, Marina
Mahecic, Davorka Herman
Grgurevic, Miaden
DIABETES, 2017, 66 : A298 - A298
[26] REAL-WORLD EFFECTIVENESS OF BISPHOSPHONATES FOR THE REDUCTION OF CLINICAL FRACTURES
Abelson, Abby
Thomas, Thierry P.
Gold, Deborah T.
Lange, Jeff L.
Ringe, Johann D.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S218 - S219
[27] Do clinical trials for new disease modifying treatments include real world patients with multiple sclerosis?
Ignacio Rojas, Juan
Pappolla, Agustin
Patrucco, Liliana
Cristiano, Edgardo
Sanchez, Francisco
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
[28] Real-world persistence of multiple sclerosis disease-modifying therapies
Tallantyre, Emma C.
Dobson, Ruth
Froud, Joseph L. J.
St John, Frederika A.
Anderson, Valerie M.
Arun, Tarunya
Buckley, Lauren
Evangelou, Nikos
Ford, Helen L.
Galea, Ian
George, Sumi
Gray, Orla M.
Hibbert, Aimee M.
Hu, Mo
Hughes, Stella E.
Ingram, Gillian
Kalra, Seema
Lim, Chia-Hui E.
Mathews, Joela T. M.
McDonnell, Gavin V.
Mescall, Naomi
Norris, Sam
Ramsay, Stephen J.
Rice, Claire M.
Russell, Melanie J.
Shawe-Taylor, Marianne J.
Williams, Thomas E.
Harding, Katharine E.
Robertson, Neil P.
EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
[29] Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis
Jin, Yinzhu
Liu, Jun
Desai, Rishi J.
Kim, Seoyoung C.
ACR OPEN RHEUMATOLOGY, 2023, 5 (11) : 571 - 580
[30] Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
Luca Prosperini
Shalom Haggiag
Serena Ruggieri
Carla Tortorella
Claudio Gasperini
CNS Drugs, 2023, 37 : 915 - 927

← 1 2 3 4 5 →